OBJECTIVE: To assess the rate of angiographic restenosis in patients with end stage renal disease after elective coronary angioplasty. DESIGN: A retrospective case-control study of 20 patients with end stage renal disease and 20 sex and age matched controls without renal disease, who had undergone primarily successful coronary angioplasty. Control coronary angiography was performed regardless of worsening or renewed incidence of anginal symptoms. MAIN OUTCOME MEASURES: Group comparison of coronary morphology, as evaluated by quantitative coronary angiography, and of cardiovascular risk factors. RESULTS: The rate of angiographic restenosis was 60% in patients with renal disease and 35% in controls. In patients with end stage renal disease the following differences (mean (SD) were found versus controls: raised plasma fibrinogen (483 (101) v 326 (62) mg/dl, p < 0.001); raised plasma triglyceride (269 (163) v 207 (176) mg/dl, p < 0.01); smaller diameter of the coronary reference segment (2.59 (0.87) v 2.90 (0.55) mm, p < 0.10); smaller minimum luminal diameter of the dilated stenosis (0.77 (0.46) v 0.97 (0.27) mm, p < 0.05). Discriminant analysis showed that minimum luminal diameter before angioplasty (r = -0.79) and fibrinogen (r = +0.34) had the highest statistical association with restenosis. CONCLUSIONS: The high rate of angiographic restenosis in patients with end stage renal disease seems to be related to the size of the vessel dilated and to an increased prothrombotic risk, as indicated by higher fibrinogen concentrations.
OBJECTIVE: To assess the rate of angiographic restenosis in patients with end stage renal disease after elective coronary angioplasty. DESIGN: A retrospective case-control study of 20 patients with end stage renal disease and 20 sex and age matched controls without renal disease, who had undergone primarily successful coronary angioplasty. Control coronary angiography was performed regardless of worsening or renewed incidence of anginal symptoms. MAIN OUTCOME MEASURES: Group comparison of coronary morphology, as evaluated by quantitative coronary angiography, and of cardiovascular risk factors. RESULTS: The rate of angiographic restenosis was 60% in patients with renal disease and 35% in controls. In patients with end stage renal disease the following differences (mean (SD) were found versus controls: raised plasma fibrinogen (483 (101) v 326 (62) mg/dl, p < 0.001); raised plasma triglyceride (269 (163) v 207 (176) mg/dl, p < 0.01); smaller diameter of the coronary reference segment (2.59 (0.87) v 2.90 (0.55) mm, p < 0.10); smaller minimum luminal diameter of the dilated stenosis (0.77 (0.46) v 0.97 (0.27) mm, p < 0.05). Discriminant analysis showed that minimum luminal diameter before angioplasty (r = -0.79) and fibrinogen (r = +0.34) had the highest statistical association with restenosis. CONCLUSIONS: The high rate of angiographic restenosis in patients with end stage renal disease seems to be related to the size of the vessel dilated and to an increased prothrombotic risk, as indicated by higher fibrinogen concentrations.
Authors: M Nobuyoshi; T Kimura; H Nosaka; S Mioka; K Ueno; H Yokoi; N Hamasaki; H Horiuchi; H Ohishi Journal: J Am Coll Cardiol Date: 1988-09 Impact factor: 24.094
Authors: P W Serruys; H E Luijten; K J Beatt; R Geuskens; P J de Feyter; M van den Brand; J H Reiber; H J ten Katen; G A van Es; P G Hugenholtz Journal: Circulation Date: 1988-02 Impact factor: 29.690
Authors: P P Leimgruber; G S Roubin; J Hollman; G A Cotsonis; B Meier; J S Douglas; S B King; A R Gruentzig Journal: Circulation Date: 1986-04 Impact factor: 29.690
Authors: R Gokal; C Jakubowski; J King; L Hunt; S Bogle; R Baillod; F Marsh; C Ogg; D Oliver; M Ward Journal: Lancet Date: 1987-11-14 Impact factor: 79.321
Authors: W L Hellerstedt; W J Johnson; N Ascher; C M Kjellstrand; R Knutson; F L Shapiro; S Sterioff Journal: Mayo Clin Proc Date: 1984-11 Impact factor: 7.616
Authors: Nicola Kumar; Christopher S R Baker; Kakit Chan; Neill Duncan; Iqbal Malik; Andrew Frankel; Damien R Ashby; Adam McLean; Andrew Palmer; Tom D Cairns; David Taube Journal: Clin J Am Soc Nephrol Date: 2011-07-07 Impact factor: 8.237
Authors: K Ivens; F Gradaus; P Heering; F C Schoebel; M Klein; H D Schulte; B E Strauer; B Grabensee Journal: Int Urol Nephrol Date: 2001 Impact factor: 2.370
Authors: Heli M Lahtela; Tuomas O Kiviniemi; Marja K Puurunen; Axel Schlitt; Andrea Rubboli; Antti Ylitalo; José Valencia; Gregory Y H Lip; K E Juhani Airaksinen Journal: PLoS One Date: 2015-06-01 Impact factor: 3.240
Authors: Giulio G Stefanini; Masanori Taniwaki; Bindu Kalesan; Lorenz Räber; Stefan Stortecky; Thomas Pilgrim; Yoshinobu Onuma; Sigmund Silber; Patrick W Serruys; Bernhard Meier; Peter Jüni; Stephan Windecker Journal: PLoS One Date: 2014-09-03 Impact factor: 3.240